Abstract:Background: Graves' ophthalmopathy (GO), the common extrathyroidal manifestation in Graves' hyperthyroidism (GH), often has an unsatisfactory therapeutic effect due to late diagnosis. Methods: Firstly, we proposed a novel score termed TCR Clonal expansion and chaos Score (TCS) to characterize VJ. TCS score equals to the ratio between clonal expansion of TCR V-J combination and chaos of peptide similarity. Then, we sequenced the RNA transcripts from the complementarity determining region 3 (CDR3) of TCR Vβ from 100 peripheral blood samples, including 43 and 57 stable GH. Random forest method was applied to select candidate features with the best performance to classify and GH. Lastly, this model was applied in an independent validation dataset consisting of 18 stable samples and 17 samples who progressed to in the follow up visit. Findings: The leave-one-out cross validation showed this model with a sensitivity of 87.88% and a specificity of 81.08% to differentiate from stable GH. And it achieved a sensitivity and specificity of 70.59% and 72.22% for prediction progression in GH. Specifically, 12 of the 17 patients who were as developed symptoms of eyelid swelling, chemosis or proptosis in a median of 6.5 months (4-9.75 months, IQR). In addition, GO-free survival analysis demonstrated that predicted GO patients (n = 17) were significant difference with predicted GH patients (n = 18) in progression (P = 0.015, log-rank test). Interpretation: Our finding provides a proof of concept for diagnosis and prognosis using TCR repertoire and may help develop novel prophylactic strategy for and other autoimmune diseases. Funding Statement: This work was supported by the National Key R&D Program of China (grant NO. 2018YFC1311500 (B.S.), 2017YFC0907500 (K.Y.) and 2018YFC0910400 (K.Y.)), National Science Foundation of China (NSFC) (grant NO. 81670725 (B.S.), 81500690 (Y.W.), 31671372 (K.Y.), 61702406 (X.Y.)), the Clinical Research Award of the First Affiliated Hospital of Xi'an Jiaotong University, China (grant NO. XJTU1AF-CRF-2017-001 (B.S.)), Natural Science Foundation of Shaanxi Province (2018JM70990 (Y.W.)), Key Research and Development Project of Shaanxi Province (grant NO. 2017ZDXM-SF-060 (B.S.)), the Fundamental Research Funds for the Central Universities (1191329875 (Y.W.)), China Postdoctoral Science Foundation (224646(Y.W.)). Declaration of Interests: The authors have declared that no conflict of interest exists. Ethics Approval Statement: This study was approved by the Ethic Committee of the First Affiliated Hospital of Xi’an Jiaotong University (KYLLSL-2015-004-01). Informed consent was sought from all patients before screening and study entry.

A multifactorial screening model based on the Graves ophthalmopathy quality of life scores in dysthyroid optic neuropathy

Risk prediction of dysthyroid optic neuropathy based on CT imaging features combined the bony orbit with the soft tissue structures

Using 24-H Intraocular Pressure-Related Patterns to Identify Open-Angle Glaucoma in Thyroid Eye Disease

Visual function changes of dysthyroid optic neuropathy and ROC curve analysis for early diagnostic indicators

Functional and Morphological Brain Alterations in Dysthyroid Optic Neuropathy: A Combined Resting‐State fMRI and Voxel‐Based Morphometry Study

Analysis of the Impact of Ambulatory Care Based on Social Support on the Quality of Life of Patients with Graves' Ophthalmopathy

Bridging and Validation of the Specific Graves' Ophthalmopathy Quality of Life (GO-QOL) Questionnaire with Health State Utility Values

Severity Identification of Graves Orbitopathy via Random Forest Algorithm

Optic nerve compression associated with visual cortex functional alteration in dysthyroid optic neuropathy: A combined orbital and brain imaging study

Reduced Contrast Sensitivity Function Correlated with Superficial Retinal Capillary Plexus Impairment in Early Stage of Dysthyroid Optic Neuropathy

Altered Static and Dynamic Brain Functional Topological Organization in Patients With Dysthyroid Optic Neuropathy

Graves′ Ophthalmopathy: Emphasis on Assessment

Integrated Proteomics and Metabolomics Analyses of Serum in Chinese Patients with Severe and Active Graves' Orbitopathy: A Cross-sectional Study

Novel Observational Study Protocol to Develop a Prediction Model That Identifies Patients with Graves' Ophthalmopathy Insensitive to Intravenous Glucocorticoids Pulse Therapy.

GO-QOL--disease-specific quality of life questionnaire in Graves' orbitopathy

Predicting the early risk of ophthalmopathy in Graves' disease patients using TCR repertoire

Multi-Parametric Diffusion Tensor Imaging of The Optic Nerve for Detection of Dysthyroid Optic Neuropathy in Patients With Thyroid-Associated Ophthalmopathy

Diagnosis of dysthyroid optic neuropathy: combined value of orbital MRI and intracranial visual pathway diffusion kurtosis imaging

Diagnosis and stage of Graves' ophthalmopathy: Efficacy of quantitative measurements of the lacrimal gland based on 3-T magnetic resonance imaging.

Development and validation of the 40-item Glaucoma Visual Functioning Questionnaire

Preliminary Diffusion‐Tensor Imaging Evidence for Trans‐Synaptic Axonal Degeneration in Dysthyroid Optic Neuropathy Due to Thyroid‐Associated Ophthalmopathy